Freestone Grove Partners’s MaxLinear MXL Stock Holding History

Freestone Grove Partners’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$524K	Sell	4,089 -3,199	-44%	-$226K	﹤0.01%	654
2026 Q1	$127K	Buy	+7,288	New	+$131K	﹤0.01%	786

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Freestone Grove Partners's MXL Position: Q2 2026 in Review

Freestone Grove Partners reduced its MaxLinear (MXL) stake by 44% in Q2 2026, selling an estimated $226K and leaving 4,089 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Freestone Grove Partners first reported a position in MXL in Q1 2026 and has held it in 2 quarters since. 433 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

Freestone Grove Partners held 4,089 shares of MaxLinear worth $524K as of Q2 2026.
Freestone Grove Partners sold 3,199 MaxLinear shares in Q2 2026, an estimated $226K.
MaxLinear made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #654 holding.
Freestone Grove Partners first reported a position in MaxLinear in Q1 2026 and has held it in 2 quarters since.
433 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.